GOSTAR's proprietary data set underwent rigorous analysis and large-scale ML model building to predict drug solubility in a recent joint study. X-Chem's RosalindAI delivered superior and actionable results than other similar analyses using well-known publically available datasets
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types
The drug is aimed at treating Covid-19 patients with Acute Respiratory Distress Syndrome (ARDS)
Under the terms of the agreement, Arrakis will lead research activities for the identification of RNA-targeted small molecule (rSM) binders against a broad set of targets nominated by Amgen
Hitz shall assume new role from January 17th, 2022
The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness
Subscribe To Our Newsletter & Stay Updated
